SCHEMBL22112574

SCHEMBL22112574

O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)N(CC(=O)NCC(CNC(=O)CN(Cc2ccccc2)C(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)(CNC(=O)CN(Cc2ccccc2)C(=O)CN2CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC2)CNC(=O)CN(Cc2ccccc2)C(=O)CN2CCN(CC(=O)O)CCN(CC(O)O)CCN(CC(=O)O)CC2)Cc2ccccc2)CCN(CC(=O)O)CC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
FOLH1 Q04609 3/20 0.37
CTSL P07711 1/20 0.36
CTSS P25774 1/20 0.36
F2 P00734 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PRMT5 O14744 1/20 0.35
WDR77 Q9BQA1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22069305 0.93 HDAC1 (0.42) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL20200044 0.91 HDAC1 (0.38) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL22069430 0.87 MEN1 (0.40) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL23656474 0.86 MEN1 (0.39) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL22112578 0.84 CACNA2D1 (0.38) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL22069494 0.83 MCHR1 (0.40) HDAC1HDAC6MEN1KMT2AALDH1A1
SCHEMBL20200022 0.83 KMT2A (0.36) MEN1KMT2AALDH1A1KDM4E
SCHEMBL22112591 0.81
SCHEMBL22112422 0.79 HSD17B10 (0.34) ALDH1A1POLBKDM4ETDP1SMN1; SMN2
SCHEMBL22112589 0.78 KDM4E (0.31) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544964-B1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING Bayer Pharma AG (DE) 2020-06-17 EP disclosed